Position in CAI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$392,325
-$1,321 QoQ
Shares Held
22,016
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#136
of 246 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CAI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PDT Partners, LLC holds $58,476,347 across 23 Biotechnology names. CAI ranks #20 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
122,041 | $14,287,339 | |
| 2 | RCUS |
Arcus Biosciences, Inc.
|
323,567 | $9,975,570 | |
| 3 | FTRE |
Fortrea Holdings Inc.
|
301,272 | $5,242,132 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
265,491 | $4,505,382 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
155,075 | $4,066,066 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
108,100 | $3,825,659 | |
| 7 | CLDX |
Celldex Therapeutics, Inc.
|
80,899 | $3,010,251 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
41,585 | $2,284,679 |
All Filings in CAI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $392,325 | 22,016 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $393,646 | 22,016 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $593,991 | 22,016 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||